Oral and inhaled glucocorticoid use and risk of Achilles or biceps tendon rupture: a population-based case-control study

References

• Elser F, Braun S, Dewing CB, Giphart JE, Millett PJ. Anatomy, function, injuries, and treatment of the long head of the biceps brachii tendon. Arthroscopy. 2014;27:581–92.
   Web of Science ®Google Scholar
• Snyder GM, Mair D, Lattermann C. Tendinopathy of the long head of the biceps. Med Sport Sci. 2012;57:76–89.
   PubMedGoogle Scholar
• Raikin SM, Garras DN, Krapchev PV. Achilles tendon injuries in a United States population. Foot Ankle Int. 2013;34:475–80.
   PubMed Web of Science ®Google Scholar
• Lantto I, Heikkinen J, Flinkkilä T, Ohtonen P, Leppilahti J. Epidemiology of Achilles tendon ruptures: increasing incidence over a 33-year period. Scand J Med Sci Sports. 2014;25:1–6.
   Google Scholar
• Seeger JD, West WA, Fife D, Noel GJ, Johnson LN, Walker AM. Achilles tendon rupture and its association with fluoroquinolone antibiotics and other potential risk factors in a managed care population. Pharmacoepidemiol Drug Saf. 2006;15:784–92.
   PubMed Web of Science ®Google Scholar
• Longo UG, Loppini M, Marineo G, Khan WS, Maffulli N, Denaro V. Tendinopathy of the tendon of the long head of the biceps. Sports Med Arthrosc. 2011;19:321–32.
   PubMed Web of Science ®Google Scholar
• Cook J, Khan K, Purdam C. Achilles tendinopathy. Man Ther. 2002;7:121–30.
   PubMed Web of Science ®Google Scholar
• Vosseller JT, Ellis SJ, Levine DS, Kennedy JG, Elliott AJ, Deland JT, et al. Achilles tendon rupture in women. Foot Ankle Int. 2013;34:49–53.
   PubMed Web of Science ®Google Scholar
• Magnan B, Bondi M, Pierantoni S, Samaila E. The pathogenesis of Achilles tendinopathy: a systematic review. Foot Ankle Surg. 2014; 20:154–9.
   PubMed Web of Science ®Google Scholar
• Kraemer R, Wuerfel W, Lorenzen J, Busche M, Vogt PM, Knobloch K. Analysis of hereditary and medical risk factors in Achilles tendinopathy and Achilles tendon ruptures: a matched pair analysis. Arch Orthop Trauma Surg. 2012;132:847–53.
   PubMed Web of Science ®Google Scholar
• Kirchgesner T, Larbi A, Omoumi P, Malghem J, Zamali N, Manelfe J, et al. Drug-induced tendinopathy: from physiology to clinical applications. Joint Bone Spine. 2014;81:485–92.
   PubMed Web of Science ®Google Scholar
• Thevendran G, Sarraf KM, Patel NK, Sadri A, Rosenfeld P. The ruptured Achilles tendon: a current overview from biology of rupture to treatment. Musculoskelet Surg. 2013;97:9–20.
   PubMedGoogle Scholar
• Van der Linden PD, Sturkenboom MCJM, Herings RMC, Leufkens HMG, Rowlands S, Stricker BHC. Increased risk of Achilles tendon rupture with quinolone antibacterial use, especially in elderly patients taking oral corticosteroids. Arch Intern Med. 2013;163:1801–7.
   Web of Science ®Google Scholar
• Blanco I, Krähenbühl S, Schlienger RG. Corticosteroid-associated tendinopathies. An analysis of the published literature and spontaneous pharmacovigilance data. Drug Saf. 2005;28:633–43.
   PubMed Web of Science ®Google Scholar
• Singh D, Pandit D, Doherty M. High dose inhaled corticosteroids can cause Achilles tendonitis. Respir Med CME. 2009;2:15–17.
   Google Scholar
• Dean BJF, Lostis E, Oakley T, Rombach I, Morrey ME, Carr AJ. The risks and benefits of glucocorticoid treatment for tendinopathy: a systematic review of the effects of local glucocorticoid on tendon. Semin Arthritis Rheum. 2014;43:570–6.
   PubMed Web of Science ®Google Scholar
• Dean BJF, Franklin SL, Murphy RJ, Javaid MK, Carr AJ. Glucocorticoids induce specific ion-channel-mediated toxicity in human rotator cuff tendon: a mechanism underpinning the ultimately deleterious effect of steroid injection in tendinopathy? Br J Sports Med. 2014;48:1620–6.
   PubMed Web of Science ®Google Scholar
• Poulsen RC, Watts AC, Murphy RJ, Snelling SJ, Carr AJ, Hulley PA. Glucocorticoids induce senescence in primary human tenocytes by inhibition of sirtuin 1 and activation of the p53/p21 pathway: in vivo and in vitro evidence. Ann Rheum Dis. 2014;73:1405–13.
   PubMed Web of Science ®Google Scholar
• Newnham D, Douglas J, Legge JS, Friend J. Achilles tendon rupture: an underrated complication of corticosteroid treatment. Thorax. 1991;46:853–4.
   PubMed Web of Science ®Google Scholar
• Muto T, Kokubu T, Mifune Y, Inui A, Harada Y, Yoshifumi, et al. Temporary inductions of matrix metalloprotease-3 (MMP-3) expression and cell apoptosis are associated with tendon degeneration or rupture after corticosteroid injection. J Orthop Res. 2014;32:1297–304.
   PubMed Web of Science ®Google Scholar
• Van Staa TP, Laan RF, Barton IP, Cohen S, Reid DM, Cooper C. Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum. 2003;48:3224–9.
   PubMed Web of Science ®Google Scholar
• Fok JS, Yong TY, Li JY. Spontaneous unilateral Achilles tendon rupture with corticosteroid use for microscopic polyangiitis. J Med Cases. 2013;4:304–6.
   Google Scholar
• Kotnis RA, Halstead JC, Hormbrey PJ. Atraumatic bilateral Achilles tendon rupture: an association of systemic steroid treatment. J Accid Emerg Med. 1999;16:378–9.
   PubMedGoogle Scholar
• Khan NF, Harrison SE, Rose PW. Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br J Gen Pract. 2010;60:e128–36.
   PubMed Web of Science ®Google Scholar
• Walley T, Mantgani A. The UK General Practice Research Database. Lancet. 1997;350:1097–9.
   PubMed Web of Science ®Google Scholar
• Cardone DA, Tallia AF, Johnson RW. Joint and soft tissue injection. Am Fam Physician. 2002;66:283–8.
   PubMed Web of Science ®Google Scholar
• Khazzam M, George MS, Churchill RS, Kuhn JE. Disorders of the long head of biceps tendon. J Shoulder Elbow Surg. 2012;21:136–45.
   PubMed Web of Science ®Google Scholar
• Hernán MA, Hernández-díaz S, Werler MM, Mitcheil AA. Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am J Epidemiol. 2002;155:176–84.
   PubMed Web of Science ®Google Scholar
• Marie I, Delafenêtre H, Massy N, Thuillez C, Noblet C. Tendinous disorders attributed to statins: a study on ninety-six spontaneous reports in the period 1990–2005 and review of the literature. Arthritis Rheum. 2008;59:367–72.
   PubMed Web of Science ®Google Scholar
• Beri A, Dwamena FC, Dwamena BA. Association between statin therapy and tendon rupture: a case-control study. J Cardiovasc Pharmacol. 2009;53:401–4.
   PubMed Web of Science ®Google Scholar
• Maron DJ, Fazio S, Linton MF. Current perspectives on statins. Circulation. 2000;101:207–13.
   PubMed Web of Science ®Google Scholar
• Ejnisman B, Monteiro GC, Andreoli CV, de Castro Pochini A. Disorder of the long head of the biceps tendon. Br J Sports Med. 2010;44:347–54.
   PubMed Web of Science ®Google Scholar
• Benthien JP, Delling G, Rüther W.[Spontaneous Achilles tendon rupture in granulomatous vasculitis]. Z Rheumatol. 2003;62:402–5.
   PubMed Web of Science ®Google Scholar
• Weinstein RS. Glucocorticoid-induced bone disease. N Engl J Med. 2011;365:62–70.
   PubMed Web of Science ®Google Scholar
• Weinstein RS. Glucocorticoid-induced osteoporosis and osteonecrosis. Endocrinol Metab Clin North Am. 2012;41:595–611.
   PubMed Web of Science ®Google Scholar
• Steinbuch M, Youket TE, Cohen S. Oral glucocorticoid use is associated with an increased risk of fracture. Osteoporos Int. 2004;15:323–8.
   PubMed Web of Science ®Google Scholar
• De Vries F, Cooper AL, Cockle SM, van Staa T-P, Cooper C. Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates. Osteoporos Int. 2009;20:1989–98.
   PubMed Web of Science ®Google Scholar